Clinical TopicsNewsPain ManagementWeb Exclusives

FDA warns of risk of death from postop codeine use in children

Share

On Aug. 15, the U.S. Food and Drug Administration (FDA) issued a warning about risk of death from postop codeine use in children following tonsillectomy and/or adenoidectomy. The warning resulted from reports of three deaths and one life-threatening case of respiratory depression. Read more.

*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.

Poll

More News